Statins, the cholesterol-lowering drugs taken by millions of people, might also help those with multiple sclerosis (MS), according to a preliminary study appearing in the May 15 Lancet.
Various studies have indicated that statins—in addition to slashing the harmful low-density lipoprotein cholesterol—have anti-inflammatory effects. Scientists reasoned that this might help MS patients, who have areas of brain tissue where the fatty sheath that insulates nerves has been stripped away by an inflammation-based immune onslaught.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.